Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Obesity

The three lifestyle factors putting a million UK adults at risk of dying early

Three factors could cut 20 years from a person’s life, experts warn

The Independent UK

Parents, not teachers, can beat child obesity

Letter: Steve Wilkinson says young pupils’ poor fitness is a cultural challenge that can only be resolved by parents’ choices

The Guardian - UK

As an NHS GP, I can now prescribe weight-loss jabs – but a quick fix for obesity is not what we need

Few patients will be eligible for the drugs. Better food regulation and social policy are far more likely to give lasting results, says GP Helen Salisbury

The Guardian - UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Rather than relying on weight-loss jabs on the NHS, encourage us all to be fitter and healthier

THE INDEPENDENT VIEW: Editorial: The health department rolling out jabs to patients who struggle with their weight must be a moment to rethink our approach to childhood obesity, so often the precursor to a lifetime of poor outcomes

The Independent UK

RFK Jr Wants Every American Wearing a Smartwatch To Track Their Health by 2029 — But Will The Data Be Safe?

RFK Jr proposes a 2029 smartwatch initiative for all Americans to track health, sparking data safety concerns. His MAHA agenda aims to combat obesity.

International Business Times UK

Some early-onset cancers are on the rise. Why?

The rates of certain early-onset cancers are on the rise. The reasons are complex, experts say.

LiveScience

New once-a-month drug could treat diabetes and obesity, scientists say

Researchers say experimental drug’s less frequent dosing could improve adherence and offer long-term control

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Trial finds weight loss drug taken monthly helps people lose 20% of body weight – but adverse GI events were ‘common’

The new drug may rival other weight loss medications such as Ozempic and Mounjaro

The Independent UK

Amgen (AMGN) Stock Falls After Mixed MariTide Trial Update

Amgen Inc (NASDAQ:AMGN) shares are trading lower by 5.7% to $272.88 Monday afternoon after the company released full results from part one of its phase two study of MariTide, its investigational obesity treatment.

Benzinga

Mounjaro becomes available on the NHS: what to know and what to do if you’re not eligible

Obesity remains one of the most pressing, and preventable, health challenges of our time. The UK is one of a number of countries undoubtedly struggling with it.

The Conversation

Majority of UK children will be overweight or obese in nine areas by 2035

Nine worst affected areas predicted to see child obesity rates rise above 50 per cent over next decade

The Independent UK

Majority of children will be overweight or obese in nine areas of England by 2035, study shows

Exclusive: Analysis by Royal Society for Public Health suggests obesity rates will rise in 90% of the country

The Guardian - UK

Can’t sleep? It might be the reason you’re putting on weight

Sleep loss is linked to poor eating habits and elevated risks for obesity and metabolic disease.

The Independent UK

London borough to completely ban junk food adverts amid obesity crisis

The policy would ban adverts for unhealthy products linked to obesity and diabetes

Evening Standard

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Weight-loss jabs could soon be among most commonly used NHS drugs, top doctor says

Patients may eventually access weight-loss jabs at pharmacies in a drive to ‘turn the tide’ on rising obesity, Professor Sir Stephen Powis says

The Independent UK

Weight loss jabs could be transformative, says outgoing NHS England official

An estimated 1.5 million people are taking weight loss jabs in the UK.

The Independent UK

Thousands to benefit as weight loss drug Mounjaro approved for new use

Australia and the United States have both approved the drug for the treatment of sleep apnoea

The Conversation

The weight loss drug Mounjaro has been approved to treat sleep apnoea. How does it work?

Last week, Australia’s Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnoea, a condition in which breathing stops and starts repeatedly during sleep.

Get all your
news in one place.

100’s of premium titles.
One news app.

LiveScience

People's mental health often improves after weight-loss surgery. A study pinpoints the real reason why.

Feeling less stigma — not losing weight — was linked to better mental health and eating behaviors after bariatric surgery.

The Independent UK

Weight-loss drugs were said to be a game changer. Turns out the benefit might be thinner than thought

Researchers from the Cleveland Clinic said discontinuation of the drugs comes with reduced weight loss

The Guardian - US

Food additive titanium dioxide likely has more toxic effects than thought, study finds

Controversial additive may be in as many as 11,000 US products and could lead to diabetes and obesity

Euronews

The slimming shot: What price are you willing to pay for a dream body?

How weight loss demand is draining Europe’s diabetes drug supply, as countries adopt varying speeds of approach to medicinal approval for dual purposes.

The Independent UK

Wegovy use spikes among teens as doctors grapple with obesity crisis

New data indicates that American teenagers are increasingly using the weight-loss drug Wegovy, as confidence in its use for young people with obesity grows among families and doctors.

Bored Panda

Before-And-After Photos Of Woman, 53, Go Viral After She Transforms Into Bodybuilding Champion

A 53-year-old from Brazil shocks social media with jaw-dropping transformation photos and inspirational messages to her thousands of fans

Barchart

Eli Lilly vs. Novo Nordisk: Which Stock Is the Winner of the Weight-Loss Drug Boom?

Both companies have established a solid presence in the weight-loss drug market, but only one of them can lead.

1 … 8 9 10 11

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.